Primary graft dysfunction in lung transplantation.

Area of Science:

• Cardiology and Thoracic Surgery
• Immunology

Background:

• Lung transplantation has advanced significantly since 1986, treating over 20,000 patients with pulmonary failure.
• Improvements in surgical techniques and perioperative care have enhanced survival rates for lung transplant recipients.

Purpose of the Study:

• To discuss the mechanisms of primary allograft dysfunction (PAD) following lung transplantation.
• To review current strategies for the prevention and treatment of PAD.
• To align with recent International Society for Heart and Lung Transplantation consensus definitions.

Main Methods:

• Review of current literature on primary allograft dysfunction.
• Discussion of mechanisms including ischemia reperfusion injury and innate immunity.
• Consideration of diagnostic criteria and management strategies.

Main Results:

• Primary allograft dysfunction affects 11-60% of lung transplant patients, depending on diagnostic criteria.
• Ischemia reperfusion injury and recipient innate immunity activation are key mechanisms of PAD.
• Despite advancements, PAD remains a major cause of morbidity, mortality, and reduced long-term allograft function.

Conclusions:

• Primary allograft dysfunction is a complex complication of lung transplantation with significant impact.
• Understanding PAD mechanisms is crucial for developing effective prevention and treatment strategies.
• Adherence to updated consensus definitions is important for consistent diagnosis and management.